Want to see NNOX full AI Analyst Report?
NNOX Stock Chart & Stats
$0.90
-$0.01(-1.14%)
At close: 4:00 PM EDT
$0.90
-$0.01(-1.14%)
Day’s Range― - ―
52-Week Range$0.73 - $4.71
Previous Close$0.89
Volume1.06M
Average Volume (3M)2.95M
Market Cap
$69.55M
Enterprise Value$121.82
Total Cash (Recent Filing)$43.85M
Total Debt (Recent Filing)$7.64M
Price to Earnings (P/E)―
Beta1.62
Next Earnings
Nov 19, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.14
Shares Outstanding78,588,640
10 Day Avg. Volume1,023,431
30 Day Avg. Volume2,952,718
Financial Highlights & Ratios
PEG Ratio-0.09
Price to Book (P/B)1.30
Price to Sales (P/S)13.93
P/FCF Ratio-4.03
Enterprise Value/Market Cap<0.01
Enterprise Value/Revenue<0.01
Enterprise Value/Gross Profit>-0.01
Enterprise Value/Ebitda>-0.01
Forecast
1Y Price Target
$3.00Price Target Upside233.33% Upside
Rating ConsensusHold
Number of Analyst Covering1
EPS Forecast (FY)-0.62
Revenue Forecast (FY)$25.89M
Bulls Say, Bears Say
Bulls Say
Growing Revenue BaseRevenue growth across teleradiology, AI/software, and imaging systems indicates improving commercial adoption. Although the base remains small, broader contributions can support a more diversified and scalable business model over time.
AI And Teleradiology ExpansionExpansion in software and teleradiology adds recurring, service-oriented revenue alongside hardware. Improving teleradiology margins and stated AI margins in the 80s could strengthen gross economics as utilization and deployments scale.
Commercial Deployment PipelineAn operational RadNet reference site and sizeable distributor pipeline can validate the platform and support broader customer adoption. Successful conversions would create installed-base opportunities for imaging, software, AI, and teleradiology services.
Bears Say
Persistent UnprofitabilityNegative gross profit means the company is not yet covering direct costs, while continuing operating and net losses consume capital. Sustainable profitability depends on substantial revenue growth, better pricing, and durable margin improvement.
Cash Burn And Going-Concern RiskLarge recurring cash outflows and limited liquidity increase dependence on external financing before breakeven, now expected in early 2027. This can constrain execution and create dilution or refinancing risk if commercialization takes longer.
Low Revenue VisibilityWithdrawing guidance signals uncertainty in converting signed partnerships into installations, activation, utilization, and recognized revenue. Reduced visibility complicates planning and raises the risk that the deployment pipeline will not fund the business as expected.
Nano-X Imaging News
NNOX FAQ
What was Nano-X Imaging Ltd.’s price range in the past 12 months?
Nano-X Imaging Ltd. lowest stock price was $0.73 and its highest was $4.71 in the past 12 months.
What is Nano-X Imaging Ltd.’s market cap?
Nano-X Imaging Ltd.’s market cap is $69.55M.
When is Nano-X Imaging Ltd.’s upcoming earnings report date?
Nano-X Imaging Ltd.’s upcoming earnings report date is Nov 19, 2026 which is in 89 days.
How were Nano-X Imaging Ltd.’s earnings last quarter?
Currently, no data Available
Is Nano-X Imaging Ltd. overvalued?
According to Wall Street analysts Nano-X Imaging Ltd.’s price is currently Undervalued.
Does Nano-X Imaging Ltd. pay dividends?
Nano-X Imaging Ltd. does not currently pay dividends.
What is Nano-X Imaging Ltd.’s EPS estimate?
Nano-X Imaging Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Nano-X Imaging Ltd. have?
Nano-X Imaging Ltd. has 78,588,640 shares outstanding.
What happened to Nano-X Imaging Ltd.’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Nano-X Imaging Ltd.?
Currently, no hedge funds are holding shares in NNOX
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Nano-X Imaging Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
$3.00 (233.33% Upside)
$3.00 (233.33% Upside)
Blogger Sentiment
Bullish
NNOX Sentiment 67%
Sector Average 61%
Sector Average 61%
Hedge Fund Trend
Increased
By 73.3K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Bought Shares
Worth $123.8K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days ▼ 2.0%
Last 30 Days ▼ 1.0%
Last 30 Days ▼ 1.0%
News Sentiment
Very Bearish
Bullish news 0%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-82.76%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
-25.91%
Trailing 12-Months
Company Description
Nano-X Imaging Ltd.
Nano-X Imaging Ltd. specializes in developing a commercial-grade tomographic imaging device that incorporates an innovative digital X-ray source, which leverages a digital micro-electro-mechanical systems (MEMS) semiconductor cathode. Beyond its hardware focus, the company also delivers teleradiology services and creates artificial intelligence (AI) applications tailored for practical use in medical imaging. Its core offerings include the Nanox.ARC, a prototype medical imaging system that integrates its proprietary digital X-ray technology, and Nanox.CLOUD, a complementary cloud-based software platform envisioned to facilitate medical screening as a service. Nano-X also operates Nanox.MARKETPLACE, a platform designed to connect imaging facilities and customers with radiologists for efficient remote interpretation of medical scans. Additionally, the company provides AI-driven software solutions to a wide range of healthcare entities, including hospitals, health maintenance organizations, integrated delivery networks, pharmaceutical companies, and insurers. These solutions are designed to analyze data from existing computed tomography (CT) scans to identify or predict undiagnosed or underdiagnosed medical conditions, such as osteoporosis and cardiovascular disease. Nano-X further offers Teleradiology Services, delivering remote imaging interpretation to radiology practices, hospitals, medical clinics, diagnostic imaging centers, urgent care facilities, and multi-specialty physician groups. Founded in 2011, Nano-X Imaging Ltd. is headquartered in Neve Ilan, Israel.
NNOX Earnings Call
Q1 2026
0:00 / 0:00
Earnings Call Sentiment|Neutral
The call presented a mix of operational progress and commercial momentum — including deployments at RadNet, large partner agreements (~360 potential systems), accelerating teleradiology and AI revenues, and cross-division integrations — but these positives are offset by material near-term financial challenges: cash decline, substantial doubt about going concern, continued quarterly cash burn, increased operating losses, withdrawal of 2026 revenue guidance, and timing delays converting agreements into recognized revenue. The tone is cautiously constructive on execution and long-term opportunity but guarded on short-term financial health.View all NNOX earnings summariesNNOX Stock 12 Month Forecast
Average Price Target
$3.00
▲(233.33% Upside)
Technical Analysis
Ownership Overview
0.33% Insiders
2.18% Mutual Funds
1.68% Other Institutional Investors
95.19% Public Companies and
Individual Investors